Detecting Pulmonary Arterial Hypertension (PAH) in Patients With Systemic Sclerosis (SSc) by Ultrasound
NCT ID: NCT02243111
Last Updated: 2016-01-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
1 participants
INTERVENTIONAL
2014-09-30
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The TPD performance in detecting PAH in SSc patients will be assessed in the study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluating Pulmonary Arterial Hypertension in Patients With Systemic Sclerosis
NCT02339961
Diagnosis of Pulmonary Embolism by Doppler Signals
NCT02652689
Correlation OF Hemodynamics in Pulmonary Hypertension With Perfusion Lung Scans
NCT00621075
Predictors of Pulmonary Hypertension in Patients With Advanced Lung Diseases
NCT02777957
PulmonAry hyperteNsion DiagnOsis: a National cohoRt reseArch
NCT06998329
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Doppler ultrasound
Recording Doppler signals from the lungs
Doppler ultrasound
Detecting Doppler signals from the lungs on the right chest wall
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Doppler ultrasound
Detecting Doppler signals from the lungs on the right chest wall
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Male or female, ≥ 18 years of age
3. Diagnosis of SSc according to 2013 ACR/EULAR SSc Classification Criteria (van den Hoogen 2013): Score ≥ 9.
4. Patients with RHC data available from measurement within 3 weeks prior to TPD assessment
5. No change in or initiation of PAH specific therapy between the last RHC and TPD
Exclusion Criteria
2. PCWP or LVEDP \> 15 mmHg
3. Any PH etiology outside Group 1 (Dana Point, 2008)
4. Pregnant women
5. Patients having severe chest wall deformity
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Echosense Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yair Molad
Role: PRINCIPAL_INVESTIGATOR
Reumatology department, Rabin medical center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Reumatology department, Rabin medical center
Petah Tikva, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DOP22_1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.